| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |